![Characterization of tumour expression markers and HLA class I and class... | Download Scientific Diagram Characterization of tumour expression markers and HLA class I and class... | Download Scientific Diagram](https://www.researchgate.net/publication/330321730/figure/fig4/AS:731591127097369@1551436325523/Characterization-of-tumour-expression-markers-and-HLA-class-I-and-class-II-in-GBM-a-The.jpg)
Characterization of tumour expression markers and HLA class I and class... | Download Scientific Diagram
![Frontiers | Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes | Immunology Frontiers | Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes | Immunology](https://www.frontiersin.org/files/MyHome%20Article%20Library/424481/424481_Thumb_400.jpg)
Frontiers | Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes | Immunology
![Human Leukocyte Antigen (HLA) Typing and Stem Cell Harvesting: Information for Donors | Memorial Sloan Kettering Cancer Center Human Leukocyte Antigen (HLA) Typing and Stem Cell Harvesting: Information for Donors | Memorial Sloan Kettering Cancer Center](https://www.mskcc.org/sites/default/files/patient_ed/human_leukocyte_antigen_hla_typing_and_stem_cell_collection_information_for_donors-129784/hla_markers.png)
Human Leukocyte Antigen (HLA) Typing and Stem Cell Harvesting: Information for Donors | Memorial Sloan Kettering Cancer Center
![Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity | eLife Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity | eLife](https://iiif.elifesciences.org/lax/34961%2Felife-34961-fig9-v1.tif/full/1500,/0/default.jpg)
Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity | eLife
![Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction - ScienceDirect Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1074761319303632-fx1.jpg)
Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction - ScienceDirect
![HLA‑mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T‑cell activation (Review) HLA‑mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T‑cell activation (Review)](https://www.spandidos-publications.com/article_images/ol/14/4/ol-14-04-4415-g02.jpg)
HLA‑mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T‑cell activation (Review)
![Development of immunocompatible pluripotent stem cells via CRISPR-based human leukocyte antigen engineering | Experimental & Molecular Medicine Development of immunocompatible pluripotent stem cells via CRISPR-based human leukocyte antigen engineering | Experimental & Molecular Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs12276-018-0190-2/MediaObjects/12276_2018_190_Fig1_HTML.png)
Development of immunocompatible pluripotent stem cells via CRISPR-based human leukocyte antigen engineering | Experimental & Molecular Medicine
![Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry - Freudenmann - 2018 - Immunology - Wiley Online Library Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry - Freudenmann - 2018 - Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/04bdee40-bc61-4d23-b36c-13cd8220d591/imm12936-fig-0001-m.jpg)
Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry - Freudenmann - 2018 - Immunology - Wiley Online Library
![HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study - The Journal of Heart and Lung Transplantation HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study - The Journal of Heart and Lung Transplantation](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/687635ff-572a-4622-b8ba-3a2b193d58d8/gr1.jpg)